AFG
NVO

ABLE Financial Group’s Novo Nordisk NVO Stock Holding History

ABLE Financial Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,934
Closed -$252K – 208
2024
Q4 		$252K Hold
2,934
– – 0.07% 166
2024
Q3 		$349K Sell
2,934
-38
-1% -$5.07K 0.11% 133
2024
Q2 		$424K Buy
2,972
+74
+3% +$9.81K 0.15% 105
2024
Q1 		$372K Sell
2,898
-421
-13% -$50.1K 0.15% 108
2023
Q4 		$343K Buy
3,319
+487
+17% +$48.2K 0.15% 104
2023
Q3 		$258K Sell
2,832
-352
-11% -$31K 0.13% 116
2023
Q2 		$258K Sell
3,184
-50
-2% -$4.08K 0.13% 113
2023
Q1 		$257K Buy
+3,234
New +$229K 0.17% 109

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

ABLE Financial Group's NVO Position: Q1 2025 in Review

ABLE Financial Group sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 2,934 shares — an estimated $252K sold.

ABLE Financial Group first reported a position in NVO in Q1 2023 and held it in 8 quarters. The position peaked at $424K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • ABLE Financial Group reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • ABLE Financial Group sold 2,934 Novo Nordisk shares in Q1 2025, an estimated $252K.
  • ABLE Financial Group first reported a position in Novo Nordisk in Q1 2023 and held it in 8 quarters.
  • ABLE Financial Group's Novo Nordisk position peaked at $424K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on ABLE Financial Group's 13F filing for Q1 2025, filed 28 Apr 2025.